terfenadine has been researched along with Pink Eye in 4 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A multiclinic, double-blind, parallel and controlled study was conducted in the 1982 spring pollen season to evaluate and compare the effects of terfenadine, 60 mg bid with those of chlorpheniramine 4 mg tid and placebo for a treatment period of seven days in patients with seasonal allergic rhinitis and conjunctivitis." | 9.05 | Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. ( Buchman, E; Buckley, CE; Cascio, FL; Chretien, JH; Foster, TS; Gershwin, ME; Gordon, WE; Jakle, C; Kemp, JP; Klemawesch, SJ, 1985) |
| "To determine whether better health-related quality of life (HRQL) is achieved by initiating treatment of seasonal (ragweed) rhinoconjunctivitis (hay fever) with a nasal steroid (fluticasone) backed up by a nonsedating antihistamine (terfenadine) or whether it is better to start with the antihistamine and add the nasal steroid when necessary." | 5.08 | First-line treatment of seasonal (ragweed) rhinoconjunctivitis. A randomized management trial comparing a nasal steroid spray and a nonsedating antihistamine. ( Ferrie, PJ; Griffith, LE; Guyatt, GH; Juniper, EF, 1997) |
| "In a double blind study patients with hay fever were treated with Astemizole or Terfenadine for 3 to 4 weeks, 12 patients with Astemizole and 6 patients with Terfenadine." | 5.05 | [Hay fever therapy with 2 non-sedating antihistaminics]. ( Bäurle, G, 1985) |
| "A multiclinic, double-blind, parallel and controlled study was conducted in the 1982 spring pollen season to evaluate and compare the effects of terfenadine, 60 mg bid with those of chlorpheniramine 4 mg tid and placebo for a treatment period of seven days in patients with seasonal allergic rhinitis and conjunctivitis." | 5.05 | Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. ( Buchman, E; Buckley, CE; Cascio, FL; Chretien, JH; Foster, TS; Gershwin, ME; Gordon, WE; Jakle, C; Kemp, JP; Klemawesch, SJ, 1985) |
| "The flurbiprofen-treated patients experienced less severe symptoms, demonstrating maximum benefit 3 to 5 days into the drug trial with some loss of effect thereafter." | 2.66 | Hay fever treatment with combined antihistamine and cyclooxygenase-inhibiting drugs. ( Brooks, CD; Karl, KJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Juniper, EF | 1 |
| Guyatt, GH | 1 |
| Ferrie, PJ | 1 |
| Griffith, LE | 1 |
| Bäurle, G | 1 |
| Kemp, JP | 1 |
| Buckley, CE | 1 |
| Gershwin, ME | 1 |
| Buchman, E | 1 |
| Cascio, FL | 1 |
| Chretien, JH | 1 |
| Foster, TS | 1 |
| Gordon, WE | 1 |
| Jakle, C | 1 |
| Klemawesch, SJ | 1 |
| Brooks, CD | 1 |
| Karl, KJ | 1 |
4 trials available for terfenadine and Pink Eye
| Article | Year |
|---|---|
First-line treatment of seasonal (ragweed) rhinoconjunctivitis. A randomized management trial comparing a nasal steroid spray and a nonsedating antihistamine.
Topics: Administration, Inhalation; Administration, Oral; Adult; Androstadienes; Anti-Allergic Agents; Conju | 1997 |
[Hay fever therapy with 2 non-sedating antihistaminics].
Topics: Arousal; Astemizole; Benzhydryl Compounds; Benzimidazoles; Clinical Trials as Topic; Conjunctivitis; | 1985 |
Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis.
Topics: Adult; Benzhydryl Compounds; Child; Clinical Trials as Topic; Conjunctivitis; Double-Blind Method; F | 1985 |
Hay fever treatment with combined antihistamine and cyclooxygenase-inhibiting drugs.
Topics: Adult; Benzhydryl Compounds; Conjunctivitis; Cyclooxygenase Inhibitors; Drug Therapy, Combination; F | 1988 |